Market News - US stock indices closed mixed, with the Dow Jones up 1.34%, the Nasdaq down 0.25%, and the S&P 500 up 0.21%. Major tech stocks mostly declined, with Oracle down over 10%, Google down over 2%, and Tesla and Nvidia down over 1% [1] - International oil prices fell, with WTI crude down 0.96% at $57.91 per barrel and Brent crude down 1.01% at $61.58 per barrel. In contrast, international gold prices rose, with spot gold up 1.06% at $4273.16 per ounce and COMEX gold futures up 1.87% at $4303.9 per ounce [1] - European stock indices closed higher, with Germany's DAX up 0.68%, France's CAC40 up 0.79%, and the UK's FTSE 100 up 0.49% [1] Industry Insights - Starcloud, a startup, successfully trained a large language model in space using Nvidia's H100 and plans to build a 5 GW solar-powered orbital data center. The CEO stated that energy costs for the orbital data center could be 10 times lower than ground-based centers [2] - The satellite communication industry is expected to exceed 200-400 billion yuan by 2030, with an annual compound growth rate of 10%-28%. The industry is at a critical turning point from "concept validation" to "scale application" [3] - Guoyi Quantum Technology's IPO was accepted, aiming to raise 1.17 billion yuan for high-end scientific instrument industrialization and quantum technology research. The company has 129 patents related to its main business [3] - The quantum computing industry is expected to reach a market size of hundreds of billions by 2025-2030, driven by technological breakthroughs and market demand. Key stocks include Keda Guokai and Deep Technology [4] - The "Intelligent Connection Future" Brain-Computer Interface International Conference will be held, focusing on the establishment of a brain-computer interface industry cluster and the initiation of international standards for the technology [5] - The global brain-computer interface medical application market is projected to reach $40 billion by 2030 and $145 billion by 2040, with significant potential in treating neurological disorders [6]

（文章来源：第一财经） 中信建投研报认为，脑机接口产业链上中游的技术进步带来下游应用端不断突破，近年来国内外在运动 恢复、语言沟通、听力重建等医疗领域的研究不断出现里程碑式成果。国家层面和各地区推出多项政策 利好行业加速发展，近期国家医保局发文为脑机接口新技术价格单独立项，其进入临床应用的服务收费 路径已经铺好。在技术革新和政策红利催化下，国内脑机接口公司有望逐步实现商业化应用。 ...

Core Insights - The integration of brain-computer interface (BCI) technology into clinical settings marks a significant advancement in medical diagnostics and treatment, allowing for real-time monitoring of intracranial pressure without invasive procedures [1][2] - The "Sixth Finger," developed by Tianjin University, utilizes non-invasive BCI technology to enable patients to control external prosthetics through thought, facilitating rehabilitation for those with motor impairments [2][3] - The BCI technology is recognized as a key future industry in China's 14th Five-Year Plan, alongside other advanced technologies, positioning it as a potential driver for economic growth [2][3] Company and Industry Summary - Tianjin University’s BCI team has successfully implemented a comprehensive approach to brain disease management, integrating diagnosis, monitoring, treatment, and prediction into a cohesive system [3] - The team has established the world's largest patent pool in the field of brain-computer interaction, with over 10% of patents held internationally, showcasing its leadership in innovation [3] - The university is committed to advancing original research and technology breakthroughs in BCI, aligning with national strategies to enhance technological self-reliance and productivity [3]

Core Insights - A new brain-machine interface called the Cortical Biointerface System (BISC) has been developed by research teams from Columbia University, Stanford University, and the University of Pennsylvania, showcasing transformative clinical potential [1][2] - BISC is a single-chip implant that is only 50 micrometers thick and approximately 3 cubic millimeters in volume, allowing for minimally invasive insertion between the brain and skull, significantly reducing surgical trauma and tissue rejection risks [1][2] - The chip integrates 65,536 electrodes and features a wireless data link with a bandwidth of 100 megabytes per second, enabling real-time transmission of brain neural signals to external computers with a data throughput at least 100 times greater than existing devices [1][2] Industry Impact - The high bandwidth and minimally invasive nature of BISC are expected to have profound implications for neuroscience and clinical medicine, potentially allowing paralyzed patients to regain control of limbs or external devices, and enabling speech for those with aphasia [2] - BISC has the potential to revolutionize the management of neurological disorders ranging from epilepsy to paralysis by transforming the cortical surface into an effective "portal" for high-bandwidth communication between the brain and AI or external devices [2][4] - The research team is currently developing a commercial version of the BISC chip to facilitate its application in preclinical and future human patient settings [3]

Core Insights - The integration of brain-computer interface (BCI) technology into clinical settings marks a significant advancement in medical diagnostics and treatment, allowing for real-time monitoring of intracranial pressure without invasive procedures [1][2] - The "Sixth Finger," developed by Tianjin University, utilizes non-invasive BCI technology to enable patients to control external prosthetics through thought, facilitating rehabilitation for those with motor impairments [2][3] - The BCI technology is recognized as a key future industry in China's 14th Five-Year Plan, alongside other advanced technologies, positioning it as a potential driver for economic growth [2][3] Company and Industry Summary - Tianjin University’s BCI team has successfully implemented a comprehensive approach to brain disease management, integrating diagnosis, monitoring, treatment, and prediction into a cohesive system [3] - The team has established the world's largest patent pool in the field of brain-computer interaction, with over 10% of patents held internationally, showcasing its leadership in innovation [3] - The university is committed to advancing original research and technology in BCI, aligning with national strategies to enhance technological self-reliance and productivity [3]

【美好医疗透露脑机接口业务进展，目前收入规模较小】12月10日，美好医疗在互动平台称，脑机接口 产品成熟度和应用场景随下游客户产品完善而性能提升。公司正与下游脑机接口客户深入合作，助力其 从实验室研发到批量出货的商业化转化。不过，目前相关业务产生的收入规模较小。 本文由 AI算法生成，仅作参考，不涉投资建议，使用风险自担 ...

人民财讯12月10日电，美好医疗（301363）12月10日在互动平台表示，脑机接口产品的成熟度和应用场 景随着下游客户产品的成熟和完善性能不断提高。公司正与下游脑机接口客户深入开展产品合作，协助 客户实现从实验室研发到批量出货的高效商业化转化，目前相关业务产生的收入规模较小。 ...

格隆汇12月10日丨美好医疗(301363.SZ)在互动平台表示，脑机接口产品的成熟度和应用场景随着下游 客户产品的成熟和完善性能不断提高。公司正与下游脑机接口客户深入开展产品合作，协助客户实现从 实验室研发到批量出货的高效商业化转化，目前相关业务产生的收入规模较小。 ...

Neuralink Neuralink 周一在博文中称，麦克马伦将担任医疗事务负责人。麦克马伦此前领导的 FDA 神经与物理医学器械办公室负责审批神经医疗设备的申请。 目前，Neuralink 等多家公司正致力于研发一种脑机接口设备，让大脑绕过身体其他部位，直接与电子设备进行通信。此类设备有望帮助瘫痪患者操作计算 机，并辅助视障人士恢复视觉功能。不过，现在还没有一款此类设备获得 FDA 批准用于长期商业用途。Neuralink 希望这类技术在未来能更广泛地普及，并 计划在 2030 年之前将其设备植入一名健康个体体内。 北京时间 12 月 10 日，据彭博社报道，埃隆・马斯克 (Elon Musk) 旗下脑机接口公司 Neuralink 周一宣布，已聘请美国食品药品监督管理局 (FDA) 下属神经 与物理医学器械办公室前主任大卫・麦克马伦 (David McMullen)。该部门正是负责监管 Neuralink 所研发的脑机植入设备。 麦克马伦长期从事脑机接口相关工作，并曾多次作为 FDA 的公开代表与脑机行业进行沟通。他一直是"植入式脑机接口协作社区"的成员。该组织由企业、 患者和研究人员组成，致力于共同制 ...

Core Insights - The recent election of Professor Deng Hongkui, a scientific founder of Beijing Beiqi Biopharmaceutical Co., Ltd., as an academician highlights the strategic investments made by 37 Interactive Entertainment in top-tier scientific projects [1][3] - The company has effectively aligned its investment strategy with national strategic development priorities, focusing on cutting-edge fields such as quantum computing and biomanufacturing [3][4] Investment Strategy - 37 Interactive Entertainment's investment logic is based on penetrating the uncertainties of technological iterations and capturing key turning points in industry explosions, guided by national strategic planning [4] - The company has concentrated its investments in areas with significant policy support and high growth potential, such as quantum computing, brain-computer interfaces, and biomanufacturing, as outlined in the "14th Five-Year Plan" [4][12] Case Studies - The cases of Huayi Quantum and Beiqi Biopharmaceutical exemplify the company's investment logic, with Huayi Quantum being a leader in the ion trap quantum computing sector and Beiqi Biopharmaceutical focusing on innovative stem cell technologies [5][6] - Huayi Quantum, emerging from Tsinghua University, has made significant advancements in quantum computing, while Beiqi Biopharmaceutical has developed groundbreaking solutions for cell therapy and regenerative medicine [5][6] Selection Criteria - The company emphasizes selecting top scientists with the ability to translate technology into industry applications, focusing on their technical accumulation and capacity for results transformation [8][11] - The founders of both Huayi Quantum and Beiqi Biopharmaceutical have demonstrated substantial contributions to their respective fields, showcasing their potential to drive industry advancements [11][12] Future Outlook - 37 Interactive Entertainment has developed a methodology for early-stage hard technology investments, focusing on selecting the right sectors and founders to ensure successful outcomes [12] - The company aims to continue supporting high-potential projects that can transition from technological value to industrial value, contributing to the development of new productive forces [12]